On 18 March, the Centers for Medicare & Medicaid Services (CMS) recommended “limiting non-essential care and expanding surge capacity into ambulatory surgical centres and other areas” to conserve resources and staff for managing COVID-19 patients. However, in a statement issued on 19 April, it said it now recognises “at this time, many areas [in the USA] have a low, or relatively low and stable incidence of COVID-19, and that it is important to be flexible and allow facilities to provide care for patients needing non-emergent, non-COVID-19 healthcare”.
The CMS adds that, as states and localities begin to stabilise, “it is important to restart care that is currently being postponed, such as certain procedural care (surgeries and procedures), chronic disease care, and, ultimately, preventive care”. The CMS advises, therefore, that if states or regions have passed the Gating Criteria, they may proceed to Phase I and directs them to the new US Government’s “opening up American again” guidelines.
According to the CMS, “maximum use” of telehealth modalities is “strongly encouraged”. However, for care that cannot be accomplished virtually, the CMS has issued recommendations (the first in a series) to guide “healthcare systems and facilities as they consider resuming in-person care of non-COVID-19 patients in regions with low incidence of COVID-19 disease”.
It says that non-COVID-19 care should be offered to patients “as clinically appropriate and within a state, locality, or facility that has the resources to provide such care and the ability to quickly respond to a surge in COVID-19 cases, if necessary”. The CMS also notes that decisions should “be consistent with public health information and in collaboration with state public health authorities”.
The recommendations review, among others, general considerations, personal protective equipment, workforce availability, facility considerations, and testing capacity. They include creating non-COVID Care (NCC) zones that “would screen all patients [and staff] for symptoms of COVID-19, including temperature checks”. Another recommendation is that such NCC zones should have “have in place steps to reduce risk of COVID-19 exposure and transmission; these areas should be separate from other facilities to the degrees possible (i.e., separate building, or designated rooms or floor with a separate entrance and minimal crossover with COVID-19 areas).”
Source CardiovasculảNews
Duc Tin Clinic
Tin tức liên quan
Performance diagnostique de l’interféron gamma dans l’identification de l’origine tuberculeuse des pleurésies exsudatives
A Mixed Phenotype of Airway Wall Thickening and Emphysema Is Associated with Dyspnea and Hospitalization for Chronic Obstructive Pulmonary Disease.
Radiological Approach to Asthma and COPD-The Role of Computed Tomography.
Significant annual cost savings found with UrgoStart in UK and Germany
Thrombolex announces 510(k) clearance of Bashir catheter systems for thromboembolic disorders
Phone: (028) 3981 2678
Mobile: 0903 839 878 - 0909 384 389